selective killing cancer cells small molecule targeting stress response ros
malignant transformation driven gain-of-function mutations oncogenes loss-of-function mutations tumour suppressor genes results cell deregulation frequently associated enhanced cellular stress example oxidative replicative metabolic proteotoxic stress dna damage adaptation stress phenotype required cancer cells survive consequently cancer cells may become dependent upon non-oncogenes ordinarily perform vital function normal cells thus targeting non-oncogene dependencies context transformed genotype may result synthetic lethal interaction selective death cancer cells used cell-based small-molecule screening quantitative proteomics approach resulted unbiased identification small molecule selectively kills cancer cells normal cells piperlongumine increases level reactive oxygen species ros apoptotic cell death cancer cells normal cells engineered cancer genotype irrespective p53 status little effect either rapidly slowly dividing primary normal cells significant antitumour effects observed piperlongumine-treated mouse xenograft tumour models apparent toxicity normal mice moreover piperlongumine potently inhibits growth spontaneously formed malignant breast tumours associated metastases mice results demonstrate ability small molecule induce apoptosis selectively cells cancer genotype targeting non-oncogene co-dependency acquired expression cancer genotype response transformation-induced oxidative stress-
